What do systematic reviews say?

Rituximab vs placebo or control

Rituximab showed no clear difference in adverse effects: arthropathy compared with placebo or control (low certainty).

• Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
  RR 3.92 [0.45, 33.98]
  2 studies · 84 participants
  Low